Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.

Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.

Albumin treatment of ischemic stroke was associated with cardiopulmonary adverse events in previous studies and a low incidence of intracranial hemorrhage. We sought to describe the neurological and cardiopulmonary adverse events in the ALIAS Part 2 Multicenter Trial.Ischemic stroke patients, aged 1...

Full description

Bibliographic Details
Main Authors: Michael D Hill, Renee H Martin, Yuko Y Palesch, Claudia S Moy, Diego Tamariz, Karla J Ryckborst, Elizabeth B Jones, David Weisman, Creed Pettigrew, Myron D Ginsberg
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4556660?pdf=render

Internet

http://europepmc.org/articles/PMC4556660?pdf=render

Similar Items